In first-time fathers, a three-week baby carrier intervention did not change salivary oxytocin levels compared with baby seat use.
In plain wordsIn new fathers, using a baby carrier did not change the body's own oxytocin levels in saliva compared with using a baby seat.
- Peptide
- Oxytocin
- Outcome
- No significant changeSalivary oxytocin level after baby carrier intervention
- Study
n = 60
- Comparator
- Baby seat (control group)
- Outcome group
- Sex hormones and fertility · Endocrine and hormones
Source sentences
The carrier intervention did not affect fathers' oxytocin levels.
2 context sentences(design, population, supporting numbers)
Sixty first-time fathers (infant age M = 11.18 weeks, SD = 2.08) were randomly assigned to a baby carrier intervention group (n = 32 fathers) or a control group (n = 28 fathers).
Before and after the intervention salivary oxytocin was measured and neural reactivity to infant crying was assessed using fMRI.
This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.